What is OnKure Therapeutics, Inc.'s return on equity?

OnKure Therapeutics, Inc. (OKUR) reported return on equity of -42.7% in Q1 2026.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

OnKure Therapeutics, Inc. OKUR Return on equity

Return on equity at other companies

PfizerPFE

10.6%—

Inhibrx Biosciences, Inc.INBX

-197.8%-2,158pp

Replimune GroupREPL

-90.9%+362pp

IDEAYA Biosciences, Inc.IDYA

-14.3%-5.0pp

Erasca, Inc.ERAS

-69.9%+77.1pp

Arcus BiosciencesRCUS

-70%+8.4pp

Other financials

Income statement

See full

Revenue-—

Operating income-$15.6M+8.1%

Net income-$15.2M+4.8%

EPS (diluted)-$1.11+6.7%

Balance sheet

See full

Cash & equivalents$192.1M+98.7%

Total debt$409.0K-57.2%

Total equity$184.4M+103%

Total assets$198.7M+98.9%

Cash flow

See full

Operating cash flow-$12.9M+7.6%

CapEx$5.0K-72.2%

Free cash flow-$12.9M+7.7%

Valuation

See full

Market cap$184.2M+72.6%

Enterprise value-$7.49M-127%

Returns & leverage

See full

Debt / equity0×0.0×

Current ratio13.8×+2.6×

Where this comes from

Calculated from OnKure Therapeutics, Inc.’s reported figures.

net income/total stockholders equity=-42.7%

Based on trailing twelve months.

The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about OnKure Therapeutics, Inc.'s return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OnKure Therapeutics, Inc.'s return on equity?: OnKure Therapeutics, Inc. (OKUR) reported return on equity of -42.7% in Q1 2026.
What does return on equity mean?: Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.